IL-21 R

IL-21 R

IL-21 R 詳細

Molecule Name
Interleukin 21 Receptor
分子の別称
IL21R,CD360,NILR
Drug Development Progress
治験薬の数2
市販薬剤の数0
研究&開発段階Phase 1 Clinical
ターゲットの別称
UNQ3121/PRO10273,Interleukin-21 receptor,IL21R,IL-21R,Interleukin 21 Receptor,Novel Interleukin Receptor,IL-21 Receptor,NILR,CD360 Antigen,CD360,IMD56,Receptors, Interleukin-21
バックグランド
Interleukin-21 receptor (IL21R) is also known as CD antigen CD360, Novel interleukin receptor (NILR), is a receptor for interleukin-21 and belongs to the type I cytokine receptor family or type 4 subfamily. IL21R contains two fibronectin type-III domains. IL21R is selectively expressed in lymphoid tissues and most highly expressed in thymus and spleen. IL21R transduces the growth promoting signal of IL21, and is important for the proliferation and differentiation of T cells, B cells, and natural killer (NK) cells.

IL-21 R 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
JS-014Exenokine-21; JS-014; AWT-008Phase 1 ClinicalAnwita Biosciences Inc
Carcinoma, Hepatocellular; Lymphoma; Neoplasms; Solid tumours
詳細
LatikafuspAMG-256Phase 1 ClinicalAmgen Inc
Solid tumours
詳細